Rezolute, Inc. (RZLT)
4.52
-0.17
(-3.62%)
USD |
NASDAQ |
Sep 01, 12:01
Rezolute Cash from Operations (TTM) : -73.48M for March 31, 2026
Cash from Operations (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash from Operations (TTM) Data
| Date | Value |
|---|---|
| March 31, 2026 | -73.48M |
| December 31, 2025 | -77.15M |
| September 30, 2025 | -70.49M |
| June 30, 2025 | -69.08M |
| March 31, 2025 | -65.60M |
| December 31, 2024 | -63.44M |
| September 30, 2024 | -62.80M |
| June 30, 2024 | -57.37M |
| March 31, 2024 | -50.20M |
| December 31, 2023 | -53.00M |
| September 30, 2023 | -47.48M |
| June 30, 2023 | -44.48M |
| March 31, 2023 | -45.24M |
| December 31, 2022 | -41.16M |
| September 30, 2022 | -40.86M |
| June 30, 2022 | -39.62M |
| March 31, 2022 | -32.66M |
| December 31, 2021 | -24.16M |
| September 30, 2021 | -23.23M |
| June 30, 2021 | -20.44M |
| March 31, 2021 | -19.36M |
| December 31, 2020 | -19.57M |
| September 30, 2020 | -18.79M |
| June 30, 2020 | -24.17M |
| March 31, 2020 | -23.85M |
| Date | Value |
|---|---|
| December 31, 2019 | -26.63M |
| September 30, 2019 | -22.80M |
| June 30, 2019 | -15.30M |
| March 31, 2019 | -15.42M |
| December 31, 2018 | -9.143M |
| September 30, 2018 | -10.64M |
| June 30, 2018 | -14.11M |
| March 31, 2018 | -13.87M |
| December 31, 2017 | -15.31M |
| September 30, 2017 | -15.25M |
| June 30, 2017 | -13.31M |
| March 31, 2017 | -12.82M |
| December 31, 2016 | -11.75M |
| September 30, 2016 | -10.94M |
| June 30, 2016 | -10.49M |
| March 31, 2016 | -9.300M |
| December 31, 2015 | -8.669M |
| September 30, 2015 | -8.124M |
| June 30, 2015 | -7.079M |
| March 31, 2015 | -7.214M |
| December 31, 2014 | -6.014M |
| September 30, 2014 | -4.640M |
| June 30, 2014 | -3.167M |
| March 31, 2014 | -1.302M |
| December 31, 2013 | -1.969M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (TTM) Benchmarks
| SELLAS Life Sciences Group, Inc. | -28.42M |
| AbbVie, Inc. | 19.51B |
| Marker Therapeutics, Inc. | -9.756M |
| Avalo Therapeutics, Inc. | -68.29M |
| Krystal Biotech, Inc. | 272.34M |